Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED90 for Intrathecal 3% Chloroprocaine for Elective Cervical Cerclage Surgery
NCT03805438Phase 4Completed
- Sponsor
- Duke University
- Start
- Feb 2019
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of chloroprocaine in Cervical insufficiency (CI), sponsored by Duke University. Primary endpoint: Effective Dose 90% of Intrathecal Chloroprocaine at 60 minutes. Started Feb 2019; status: completed.
02
Drugs
chloroprocaine
03
Conditions
Cervical insufficiency (CI)
Beyond the preview
Go deeper on NCT03805438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03805438.